Novonix (NVX) Liabilities and Shareholders Equity (2020 - 2025)

Novonix (NVX) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $282.9 million the latest figure, recorded in Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 25.13% year-over-year to $282.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 billion (up 6.49% YoY) and the FY2025 annual result came in at $282.9 million, up 25.13% from the prior year.
• Liabilities and Shareholders Equity retreated to $282.9 million in Q4 2025 per NVX's latest filing, from $326.9 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for NVX reached as high as $326.9 million in Q2 2025 and fell as low as $143.3 million in Q2 2021.
• A 5-year average of $266.2 million and a median of $279.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity jumped 176.79% — and 2024, when it declined 14.26%.
• Year by year, Liabilities and Shareholders Equity stood at $309.9 million in 2021, then retreated by 10.49% to $277.4 million in 2022, then dropped by 5.08% to $263.3 million in 2023, then declined by 14.14% to $226.1 million in 2024, then advanced by 25.13% to $282.9 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $282.9 million, $326.9 million, and $226.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.